Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study
about
HIV-Associated Pneumocystis PneumoniaPathobiology of Pneumocystis pneumonia: life cycle, cell wall and cell signal transductionHistone-modifying enzymes, histone modifications and histone chaperones in nucleosome assembly: Lessons learned from Rtt109 histone acetyltransferasesEpidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literatureAmbient air pollution associated with suppressed serologic responses to Pneumocystis jirovecii in a prospective cohort of HIV-infected patients with Pneumocystis pneumoniaInfectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients.Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humansCharacteristics and predictors of death among hospitalized HIV-infected patients in a low HIV prevalence country: BangladeshPneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.Critical importance of long-term adherence to care in HIV infected patients in the cART era: new insights from Pneumocystis jirovecii pneumonia cases over 2004-2011 in the FHDH-ANRS CO4 cohort.A Clinical Predictor Score for 30-Day Mortality among HIV-Infected Adults Hospitalized with Pneumonia in Uganda.Use of Oropharyngeal Washes to Diagnose and Genotype Pneumocystis jirovecii.Colonization by Pneumocystis jirovecii and its role in disease.Clinical and translational research in pneumocystis and pneumocystis pneumonia.Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study.Clinical review: Respiratory failure in HIV-infected patients--a changing picture.Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii.Prognostic value of C-reactive protein in HIV-infected patients with Pneumocystis jirovecii pneumonia.Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients.Diagnosis and management of Pneumocystis jirovecii infection.Virtual Screening of Phytochemicals to Novel Target (HAT) Rtt109 in Pneumocystis Jirovecii using Bioinformatics Tools.Characterization of the Pneumocystis carinii histone acetyltransferase chaperone proteins PcAsf1 and PcVps75.Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole used as First-Line Treatment for Pneumocystis jirovecii Pneumonia.A prognostic scoring tool for identification of patients at high and low risk of death from HIV-associated Pneumocystis jirovecii pneumoniaSeasonal variation in mortality of Pneumocystis jirovecii pneumonia in HIV-infected patientsReversible Cystic Lesions ofPneumocystis jiroveciiPneumonia
P2860
Q22241388-98CF4CAC-D103-42CE-8549-285651A9D87BQ26851629-9432CA83-DE1D-4589-8B6B-80548D3EFFF8Q27003952-54129CEE-D47C-470B-ADC0-23E81F41650DQ28082149-56FAC5EF-6B7F-45A0-8442-94466A985307Q28391022-8DB447FD-AB7B-4FEC-820C-F1ED54D9C533Q33688400-A0243B4E-2D92-4BD6-928E-B1DA77CE48E3Q33798273-6986B119-2EB7-469E-B404-34E572E1E37CQ34653573-6D8922EF-7008-48A6-BED7-6901BAF9B31CQ34924811-44BE1528-05E6-46DE-A669-F034AA436A3CQ35146521-C11B000B-7C58-414D-994F-A7BB7011075CQ35593126-48836ED0-F2A2-4FA0-B467-198B9348E954Q35837803-02BC3151-AD5D-474C-9F9E-2AF7FBC841F5Q35940586-695FD164-ABF6-41E3-8BB8-146999901878Q36899081-3662532A-8054-4FF0-BC32-AC70B6B1C726Q36958088-DE0B6A58-353D-4E87-B81E-1F09E94FF69CQ36998358-A52F23B1-00BA-4437-B3F5-E675336FDD5FQ37713756-278FDC89-C605-49CF-802D-DD2B7EA2D21DQ37727733-09C71561-6086-4B59-B2F0-BCCE385619CAQ38686315-A182E07D-DB44-4A71-A91A-720990FCA75BQ40297079-95AA7C50-9B79-46D1-BE0A-F88296F737FCQ40571424-98544496-981D-4B5B-88EE-AB7D58366246Q42144779-EDB454B6-2E0F-46B8-815A-12E145715844Q55519151-6B24B22B-00B8-4BF1-85A2-E74865D74F88Q57586333-97C620AA-4C9B-4D25-A5EB-500680F8CB45Q57586379-D466B15E-54CD-40CF-AABB-7006499EC574Q57610469-8643C659-E113-41C1-AB5E-90E23EEECBF0
P2860
Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predicting mortality from HIV- ...... an observational cohort study
@en
Predicting mortality from HIV- ...... an observational cohort study.
@nl
type
label
Predicting mortality from HIV- ...... an observational cohort study
@en
Predicting mortality from HIV- ...... an observational cohort study.
@nl
prefLabel
Predicting mortality from HIV- ...... an observational cohort study
@en
Predicting mortality from HIV- ...... an observational cohort study.
@nl
P2093
P2860
P356
P1433
P1476
Predicting mortality from HIV- ...... an observational cohort study
@en
P2093
A Swartzman
L G Jarlsberg
P2860
P304
P356
10.1136/THX.2009.117846
P407
P577
2009-10-12T00:00:00Z